Recruiting Friedreich Ataxia Studies in Los Angeles
About Friedreich Ataxia Clinical Trials in Los Angeles
Friedreich ataxia is a rare inherited disease that causes progressive damage to the nervous system and movement problems. It is caused by reduced frataxin protein from a GAA repeat expansion. Treatment includes supportive care, with omaveloxolone recently approved.
There are currently 1 friedreich ataxia clinical trials recruiting participants in Los Angeles, CALIFORNIA. These studies are seeking a combined 255 participants. Research is being sponsored by Biogen. Clinical trial participation is free and participants receive study-related medical care at no cost.
Friedreich Ataxia Clinical Trials in Los Angeles — FAQ
Are there friedreich ataxia clinical trials in Los Angeles?
Yes, there are 1 friedreich ataxia clinical trials currently recruiting in Los Angeles, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Los Angeles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.
Are clinical trials in Los Angeles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.
What friedreich ataxia treatments are being tested?
The 1 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for friedreich ataxia.
Data updated March 2, 2026 from ClinicalTrials.gov